BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16131524)

  • 1. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
    Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
    Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
    Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].
    Wang MZ; Saulter JY; Usuki E; Cheung YL; Hall M; Bridges AS; Loewen G; Parkinson OT; Stephens CE; Allen JL; Zeldin DC; Boykin DW; Tidwell RR; Parkinson A; Paine MF; Hall JE
    Drug Metab Dispos; 2006 Dec; 34(12):1985-94. PubMed ID: 16997912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1996 Jul; 331(1):69-78. PubMed ID: 8660685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
    Clement B; Mau S; Deters S; Havemeyer A
    Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry.
    Zhou L; Thakker DR; Voyksner RD; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
    J Mass Spectrom; 2004 Apr; 39(4):351-60. PubMed ID: 15103648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal NADH-cytochrome b5 reductase of bovine brain: purification and properties.
    Tamura M; Yubisui T; Takeshita M
    J Biochem; 1983 Nov; 94(5):1547-55. PubMed ID: 6654871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation.
    Miura A; Tampo Y; Yonaha M
    Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
    Wang MZ; Wu JQ; Bridges AS; Zeldin DC; Kornbluth S; Tidwell RR; Hall JE; Paine MF
    Drug Metab Dispos; 2007 Nov; 35(11):2067-75. PubMed ID: 17709372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase.
    Guengerich FP
    Arch Biochem Biophys; 2005 Aug; 440(2):204-11. PubMed ID: 16055078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of the protein components of the liver microsomal O2-insensitive NADH-benzamidoxime reductase.
    Clement B; Lomb R; Möller W
    J Biol Chem; 1997 Aug; 272(31):19615-20. PubMed ID: 9235969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
    Roma GW; Crowley LJ; Barber MJ
    Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase.
    Hodnick WF; Sartorelli AC
    Cancer Res; 1993 Oct; 53(20):4907-12. PubMed ID: 8402680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human liver P450s and cytochrome b5 in the reductive metabolism of 3'-azido-3'-deoxythymidine (AZT) to 3'-amino-3'-deoxythymidine.
    Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Yang MX; Lasker JM; Sommadossi JP
    Biochem Pharmacol; 1998 Mar; 55(6):757-66. PubMed ID: 9586947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.